Leishmania donovani pteridine reductase 1: Biochemical properties and structure-modeling studies.
Drug Target Discovery and Development, Central Drug Research Institute, Chattat Manzil, P.O. Box No. 173, Lucknow 226001, India.
Journal Article: Experimental Parasitology (impact factor: 1.6). 07/2008; DOI: 10.1016/j.exppara.2008.05.005
Abstract
Source: PubMed
Comments on this publication
ResearchGate members can add comments. Sign up now and post your comment!
Similar publications
Leishmania donovani pteridine reductase 1: Biochemical properties and structure-modeling studies
Experimental Parasitology.
Overexpression in Escherichia coli and purification of pteridine reductase (PTR1) from a clinical isolate of Leishmania donovani.
Protein expression and purification. 38(2):228-36.
Overexpression in Escherichia coli and purification of pteridine reductase (PTR1) from a clinical isolate of Leishmania donovani
Protein Expression and Purification.
Discovery of potent pteridine reductase inhibitors to guide antiparasite drug development.
Proceedings of the National Academy of Sciences of the United States of America. 105(5):1448-53.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.
Science & Research Jobs
PRAS-Healthcare-Clinical Informatics Scientist
Position: Other
Employer: Philips (China) Investment Co.,Ltd

